Hangzhou, China · Founded 2020 · In IPO Registration
Developer of an artificial intelligence platform designed to optimize pharmaceutical formulation processes. METis TechBio is based in Hangzhou, China and was founded in 2020. It has raised $315 million.
Last price · $/share
—
Implied valuation
—
Total raised
$314.7M
Last round
—
Cap table — not yet on record
METis TechBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of METis TechBio with a free account
·The complete investor list: 19 names
·Watch METis TechBio: the Monday email on marks, rounds and moves
